Advertisement

Topics

Role of intralesional bleomycin sclerotherapy as the sole or adjunct treatment of superficial ocular adnexal lymphatic malformations

20:00 EDT 3 Aug 2017 | Nature Publishing

Role of intralesional bleomycin sclerotherapy as the sole or adjunct treatment of superficial ocular adnexal lymphatic malformations

Eye advance online publication, August 4 2017. doi:10.1038/eye.2017.154

Authors: N Bothra, L Panda, J Sheth & D Tripathy

Original Article: Role of intralesional bleomycin sclerotherapy as the sole or adjunct treatment of superficial ocular adnexal lymphatic malformations

NEXT ARTICLE

More From BioPortfolio on "Role of intralesional bleomycin sclerotherapy as the sole or adjunct treatment of superficial ocular adnexal lymphatic malformations"

Quick Search
Advertisement